LAVIPHARM S.A. (CR) financial statements, including revenue, expenses, profit, and loss
The total revenue of LAVI for the last semiannual is 21.47 M EUR, and it's 27.10% lower compared to the previous semiannual. The net income of H2 23 is -347.00 k EUR.